Polarean Imaging PLC Notice of Results (2694J)
2023年8月15日 - 3:00PM
RNSを含む英国規制内ニュース (英語)
TIDMPOLX
RNS Number : 2694J
Polarean Imaging PLC
15 August 2023
15 August 2023
Polarean Imaging Plc
("Polarean" or the "Company")
Notice of results
Polarean Imaging Plc (AIM: POLX), a commercial-stage medical
device leader in advanced MRI scanning of the lungs, confirms that
it will be announcing its half year results for the six months
ended 30 June 2023 on Thursday, 7 September 2023.
Christopher von Jako, PhD, Chief Executive Officer, and Charles
Osborne, Chief Financial Officer, will be hosting a live online
presentation relating to the results via the Investor Meet Company
platform on Friday, 15 September 2023 at 10am BST.
The presentation is open to all existing and potential
shareholders. Questions can be submitted pre-event via your IMC
dashboard up until 9am the day before the meeting or in real time
during the presentation.
Investors can sign up to Investor Meet Company for free and add
to meet Polarean Imaging Plc here . Investors who already follow
Polarean on the Investor Meet Company platform will automatically
be invited.
Whilst the Company may not be in a position to answer every
question it receives, it will address the most prominent within the
confines of information already disclosed to the market through
regulatory notifications. A recording of the presentation will be
available on the Investor Meet Company platform afterwards.
Enquiries:
Polarean Imaging Plc www.polarean.com / www.polarean-ir.com
Christopher von Jako, PhD, Chief Via Walbrook PR
Executive Officer
Charles Osborne, Chief Financial
Officer
Stifel Nicolaus Europe Limited (NOMAD and
Sole Corporate Broker) +44 (0)20 7710 7600
Nicholas Moore / Samira Essebiyea / Kate Hanshaw (Healthcare
Investment
Banking)
Nick Adams / Nick Harland (Corporate Broking)
Walbrook PR Tel: +44 (0)20 7933 8780 or polarean@walbrookpr.com
Anna Dunphy / Phillip Marriage Mob: +44 (0)7876 741 001 / +44 (0)
7867 984 082
About Polarean ( www.polarean.com)
The Company and its wholly owned subsidiary, Polarean, Inc.
(together the "Group") are revenue-generating, medical imaging
technology companies operating in the high-resolution medical
imaging space. Polarean aspires to revolutionise pulmonary medicine
by bringing the power and safety of MRI to the respiratory
healthcare community in need of new solutions to evaluate lung
ventilation, diagnose disease, characterise disease progression,
and monitor response to treatment. By researching, developing, and
commercialising novel imaging solutions with a non-invasive and
radiation-free functional imaging platform. Polarean's vision is to
help address the global unmet medical needs of more than 500
million patients worldwide suffering with chronic respiratory
disease. Polarean is a leader in the field of hyperpolarisation
science and has successfully developed the first and only
hyperpolarised MRI contrast agent to be approved in the United
States. The company also commercialises systems (such as the HPX
hyperpolarisation system), accessories (such as Xe-specific chest
coils and phantoms) and FDA-cleared post-processing software (to
support ventilation defect analysis), to support fully integrated
modern respiratory imaging operations.
PLC-RNS-2318
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORDZGMRDDMGFZM
(END) Dow Jones Newswires
August 15, 2023 02:00 ET (06:00 GMT)
Polarean Imaging (LSE:POLX)
過去 株価チャート
から 4 2024 まで 5 2024
Polarean Imaging (LSE:POLX)
過去 株価チャート
から 5 2023 まで 5 2024